Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent
After completing $300 billion in healthcare deals over several decades, there is one deal Bausch and Lomb (BLCO) chairman and ...
Stock of the Day: Howard Hughes Holdings whipsaws as Bill Ackman revises his plan to create the next Berkshire Hathaway
Bill Ackman's Pershing Square proposed to acquire 10 million newly issued Howard Hughes shares at $90 a share — up from $85 a ...
Future Market Insights22h
Actinic Keratosis Treatment Market to Reach USD 12,282.4 Million by 2034 at a 7.2% of CAGR, Driven by Rising Skin Cancer Concerns
The actinic keratosis treatment market is expected to grow from USD 6.13 billion in 2024 to USD 12.28 billion by 2034, at a CAGR of 7.2%. Increasing concerns over skin cancer and advancements in ...
Rosacea Treatment Market Set For Robust Growth To USD 3.70 Billion By 2032 SNS Insider
Rosacea Treatment Market Valued at USD 2.07B in 2023, the market is forecast to grow at a CAGR of 6.64% from 2024 to 2032, driven by rising ...
MarketWatch23h
S&P 500 Pharmaceuticals Industry Index
IPC Indice de Precios Y Cotizaciones 54,077.94-82.17-0.15% ...